# BridgeBio Pharma, Inc.: Form 8-K, filed Jul 3, 2019

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: 8-K
- Filed: 2019-07-03
- Accepted by EDGAR: Jul 3, 2019, 16:34 ET
- Period: 2019-06-26
- Accession: 0001193125-19-189260
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000119312519189260/d763414d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000119312519189260/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000119312519189260/d763414d8k.htm

Filed Jul 3, 2019.
Source: SEC EDGAR, the filing index for accession 0001193125-19-189260. Last ingested by Listed: Nov 12, 2026, 17:56 ET. No prices; not investment advice.
